CS-Keys

CS-Keys

closed
Biotechnology company discovers and develops cancer-associated biomarkers using proteomics.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD39—58m (Dealroom.co estimates Jan 2008.)
Indianapolis Indiana (HQ)
  • Edit
DateInvestorsAmountRound

$290k

Seed

$6.3m

Series A
Total FundingAUD10.2m

Recent News about CS-Keys

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.